| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 112.92× | 112.92× | 153.62× | 127.51× | 207.39× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1,064.15× | 1,064.15× | 1,530.91× | 1,629.21× | 3,182.63× | ||
| 143.26× | 143.26× | 268.04× | 248.60× | 428.71× | ||
| 1,033.81× | 1,033.81× | 1,416.49× | 1,508.12× | 2,961.31× | ||
| 0.36× | 0.32× | 0.20× | 0.23× | 0.12× | ||
| 0.25× | 0.25× | 0.19× | 0.20× | 0.10× | ||
| −4.80× | −4.80× | −4.98× | −0.68× | 10.77× | ||
| −5.56× | −5.56× | −4.74× | −1.19× | 354.60× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Inventory Days (DIO) | 207.39 | 127.51 | 153.62 | 112.92 | 112.92 | |
| Receivable Days (DSO) | 3,182.63 | 1,629.21 | 1,530.91 | 1,064.15 | 1,064.15 | |
| Payable Days (DPO) | 428.71 | 248.60 | 268.04 | 143.26 | 143.26 | |
| Cash Conversion Cycle (days) | 2,961.31 | 1,508.12 | 1,416.49 | 1,033.81 | 1,033.81 | |
| Working Capital Turnover | 0.12 | 0.23 | 0.20 | 0.32 | 0.36 | |
| Asset Turnover | 0.10 | 0.20 | 0.19 | 0.25 | 0.25 | |
| Cash Conversion (CFO/Net Income) | 10.77 | -0.68 | -4.98 | -4.80 | -4.80 | |
| CFO/EBITDA | 354.60 | -1.19 | -4.74 | -5.56 | -5.56 |